Literature DB >> 16115025

Stimulation of vascular smooth muscle cell migration by macrophage migration inhibitory factor.

B H G J Schrans-Stassen1, H Lue, D G P Sonnemans, J Bernhagen, M J Post.   

Abstract

Macrophage migration inhibitory factor (MIF) is a well known proinflammatory factor that influences the migration and proliferation of various cell types, predominantly monocytes and macrophages. Recent evidence suggests an important role for MIF in the progression of atherosclerosis and restenosis. For this reason, we studied the effect of MIF on platelet-derived growth factor-BB (PDGF-BB)-induced migration and PDGF receptor protein expression in vascular smooth muscle cells (VSMCs). Furthermore, the possibility of MIF influencing the migration of VSMCs was investigated. Our results show that short-term incubation of MIF is able to enhance PDGF-BB-induced migration. Long-term incubation decreases PDGF-BB-induced migration, but preserves a short-term stimulatory effect. These effects are not regulated at the level of PDGF receptor protein expression. MIF also acts as a chemoattractant for VSMCs, with a maximum response at 15 ng/ml. In contrast, the proliferation of VSMCs was unaffected by MIF. We conclude that MIF has a biphasic effect on VSMC migration. It remains unclear whether this effect is direct or involves the secretion of unidentified promigratory factors. Exogenous MIF does not stimulate VSMC proliferation; however, a role for MIF in proliferation cannot be fully ruled out. In view of the known key contributions of macrophage-derived MIF and VSMCs, the observed effects may well play a role in the progression of atherosclerosis and restenosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115025     DOI: 10.1089/ars.2005.7.1211

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  8 in total

Review 1.  Chemokine-like functions of MIF in atherosclerosis.

Authors:  Andreas Schober; Jürgen Bernhagen; Christian Weber
Journal:  J Mol Med (Berl)       Date:  2008-04-02       Impact factor: 4.599

2.  Hypoxia stimulates the expression of macrophage migration inhibitory factor in human vascular smooth muscle cells via HIF-1alpha dependent pathway.

Authors:  Hua Fu; Fengming Luo; Li Yang; Wenchao Wu; Xiaojing Liu
Journal:  BMC Cell Biol       Date:  2010-08-20       Impact factor: 4.241

Review 3.  Role of smooth muscle cells in the initiation and early progression of atherosclerosis.

Authors:  Amanda C Doran; Nahum Meller; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

4.  Macrophage Migration Inhibitory Factor Mediates Proliferative GN via CD74.

Authors:  Sonja Djudjaj; Hongqi Lue; Song Rong; Marios Papasotiriou; Barbara M Klinkhammer; Stephanie Zok; Ole Klaener; Gerald S Braun; Maja T Lindenmeyer; Clemens D Cohen; Richard Bucala; Andre P Tittel; Christian Kurts; Marcus J Moeller; Juergen Floege; Tammo Ostendorf; Jürgen Bernhagen; Peter Boor
Journal:  J Am Soc Nephrol       Date:  2015-10-09       Impact factor: 10.121

5.  Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease.

Authors:  Arif Yüksel; Ferda Bilgir; Oktay Bilgir; Mehmet Calan; Giray Bozkaya
Journal:  Clinics (Sao Paulo)       Date:  2015-03-01       Impact factor: 2.365

Review 6.  IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.

Authors:  Xuewei Ding; Wei Xiang; Xiaojie He
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

7.  Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis.

Authors:  Sabine Tillmann; Jürgen Bernhagen; Heidi Noels
Journal:  Front Immunol       Date:  2013-05-16       Impact factor: 7.561

8.  Macrophage migration inhibitory factor promotes cardiac stem cell proliferation and endothelial differentiation through the activation of the PI3K/Akt/mTOR and AMPK pathways.

Authors:  Jinjin Cui; Fengyun Zhang; Yongshun Wang; Jingjin Liu; Xing Ming; Jingbo Hou; Bo Lv; Shaohong Fang; Bo Yu
Journal:  Int J Mol Med       Date:  2016-03-29       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.